Nautilus Biotechnology annual total assets
2020
2021
2022
2023
2024
2025
Nautilus Biotechnology Total Assets Growth & History (NAUT)
Nautilus Biotechnology's total assets was $191.1M for fiscal 2025.
View full Nautilus Biotechnology company overviewNautilus Biotechnology annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $191.1M | −$51.6M | −21.27% |
| 2024 | 2024-12-31 | $242.7M | −$62.8M | −20.56% |
| 2023 | 2023-12-31 | $305.6M | −$44.5M | −12.71% |
| 2022 | 2022-12-31 | $350.1M | −$48.4M | −12.15% |
| 2021 | 2021-12-31 | $398.4M | $313.4M | +368.70% |
| 2020 | 2020-12-31 | $85.0M | — | — |
Nautilus Biotechnology quarterly total assets
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $163.6M | −$49.6M | −23.27% |
| Q1 2026 | 2026-03-31 | $177.8M | −$49.9M | −21.92% |
| Q4 2025 | 2025-12-31 | $191.1M | −$51.6M | −21.27% |
| Q3 2025 | 2025-09-30 | $200.9M | −$58.8M | −22.64% |
| Q2 2025 | 2025-06-30 | $213.2M | −$59.6M | −21.84% |
| Q1 2025 | 2025-03-31 | $227.7M | −$61.0M | −21.12% |
| Q4 2024 | 2024-12-31 | $242.7M | −$62.8M | −20.56% |
| Q3 2024 | 2024-09-30 | $259.7M | −$58.6M | −18.42% |
| Q2 2024 | 2024-06-30 | $272.7M | −$58.0M | −17.54% |
| Q1 2024 | 2024-03-31 | $288.6M | −$57.2M | −16.55% |
| Q4 2023 | 2023-12-31 | $305.6M | −$44.5M | −12.71% |
| Q3 2023 | 2023-09-30 | $318.3M | −$41.0M | −11.40% |
| Q2 2023 | 2023-06-30 | $330.8M | −$40.9M | −11.01% |
| Q1 2023 | 2023-03-31 | $345.9M | −$38.8M | −10.08% |
| Q4 2022 | 2022-12-31 | $350.1M | −$48.4M | −12.15% |
| Q3 2022 | 2022-09-30 | $359.3M | −$26.0M | −6.76% |
| Q2 2022 | 2022-06-30 | $371.7M | −$21.6M | −5.48% |
| Q1 2022 | 2022-03-31 | $384.7M | $234.2M | +155.60% |
| Q4 2021 | 2021-12-31 | $398.4M | $313.4M | +368.70% |
| Q3 2021 | 2021-09-30 | $385.3M | $234.4M | +155.28% |
| Q2 2021 | 2021-06-30 | $393.3M | — | — |
| Q1 2021 | 2021-03-31 | $150.5M | — | — |
| Q4 2020 | 2020-12-31 | $85.0M | — | — |
| Q3 2020 | 2020-09-30 | $151.0M | — | — |
Nautilus Biotechnology total assets trends
Over the last five fiscal years, Nautilus Biotechnology's total assets increased from $85.0M to $191.1M, a change of $106.1M. The latest reported quarter, Q2 2026, shows $163.6M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nautilus Biotechnology source filings ↗